Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Immunomodulating options for liver transplant patients.

Zarrinpar A, Busuttil RW.

Expert Rev Clin Immunol. 2012 Aug;8(6):565-78; quiz 578. Review.

PMID:
22992151
2.

[Advances in immunossuppression in liver transplantation].

Olivera-Martínez MA.

Rev Invest Clin. 2005 Mar-Apr;57(2):237-43. Review. Spanish.

PMID:
16524064
3.

Liver transplant: a primer.

Movahedi Z, Holt CD, Saab S.

Exp Clin Transplant. 2010 Jun;8(2):83-90. Review.

4.

Overview of immunosuppression in liver transplantation.

Pillai AA, Levitsky J.

World J Gastroenterol. 2009 Sep 14;15(34):4225-33. Review.

5.

Calcineurin inhibitors in liver transplantation: to be or not to be.

Castroagudín JF, Molina E, Varo E.

Transplant Proc. 2011 Jul-Aug;43(6):2220-3. doi: 10.1016/j.transproceed.2011.05.012.

PMID:
21839238
6.

Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.

Rafecas A, Lladó L, Albiol MT, Ramos E, Torras J, Fabregat J, Lama C, Busquets J, Ibáñez L, Figueras J, Jaurrieta E.

Transplant Proc. 2002 Feb;34(1):107. No abstract available.

PMID:
11959209
7.

Operational tolerance: past lessons and future prospects.

Levitsky J.

Liver Transpl. 2011 Mar;17(3):222-32. doi: 10.1002/lt.22265. Review.

8.
9.

Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.

Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.

Nephrology (Carlton). 2008 Apr;13(2):171-6. doi: 10.1111/j.1440-1797.2007.00859.x.

PMID:
18275507
10.

Immunosuppression in liver transplantation.

Everson GT, Trotter JF, Kugelmas M, Forman L.

Minerva Chir. 2003 Oct;58(5):725-40. Review.

PMID:
14603151
11.

Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection.

Boleslawski E, Conti F, Sanquer S, Podevin P, Chouzenoux S, Batteux F, Houssin D, Weill B, Calmus Y.

Transplantation. 2004 Jun 27;77(12):1815-20.

PMID:
15223897
12.

Evidence for immunosuppression in lung transplantation.

Hopkins PM, McNeil K.

Curr Opin Organ Transplant. 2008 Oct;13(5):477-83. doi: 10.1097/MOT.0b013e32831040bf. Review.

PMID:
19060529
13.

Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.

Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.

Pediatr Transplant. 2006 Dec;10(8):938-42.

PMID:
17096762
14.

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.

DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G.

Liver Transpl. 2008 May;14(5):651-9. doi: 10.1002/lt.21429.

15.

Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.

Abdelmalek MF, Humar A, Stickel F, Andreone P, Pascher A, Barroso E, Neff GW, Ranjan D, Toselli LT, Gane EJ, Scarola J, Alberts RG, Maller ES, Lo CM; Sirolimus Liver Conversion Trial Study Group.

Am J Transplant. 2012 Mar;12(3):694-705. doi: 10.1111/j.1600-6143.2011.03919.x. Epub 2012 Jan 10.

16.

Pharmacologic immunosuppression.

Barshes NR, Goodpastor SE, Goss JA.

Front Biosci. 2004 Jan 1;9:411-20. Review.

PMID:
14766378
17.

Sirolimus conversion for renal dysfunction in liver transplant recipients: the devil really is in the details….

McKenna GJ, Trotter JF.

Am J Transplant. 2012 Mar;12(3):521-2. doi: 10.1111/j.1600-6143.2011.03922.x. Epub 2012 Feb 2. No abstract available.

18.

Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2 years.

Engelen MA, Amler S, Welp H, Vahlhaus C, Gunia S, Sindermann JR, Rothenburger M, Stypmann J.

Transplantation. 2011 May 27;91(10):1159-65. doi: 10.1097/TP.0b013e31821774bd.

PMID:
21478817
19.

Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?

Nashan B.

Transplant Rev (Orlando). 2009 Jan;23(1):47-52. doi: 10.1016/j.trre.2008.08.005. Review.

PMID:
19027616
20.

Supplemental Content

Support Center